Cervical mucus granulocyte macrophage colony stimulating factor and interleukin-2 soluble receptor in women using copper intrauterine contraceptive devices

Contraception

Volumn 66, Issue 2, 2002, Pages 129-132

  Shobokshi, Amal ^a   Shaarawy, Mohamed ^b  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Copper intrauterine device; Granulocyte macrophage colony stimulating factor; IL 2 soluble receptor

Indexed keywords

COPPER INTRAUTERINE DEVICE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2 RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOMETRIUM; FEMALE; FEMALE FERTILITY; HUMAN; INFLAMMATION; INTRAUTERINE CONTRACEPTIVE DEVICE; SAMPLING; UTERINE CERVIX MUCUS;

ADULT; CERVIX MUCUS; CONTRACEPTION; CYTOKINES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTRAUTERINE DEVICES, COPPER; RECEPTORS, INTERLEUKIN-2;

EID: 0036669795     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(02)00331-1     Document Type: Article

References (19)

1. Mishell D.R. Intrauterine devices. Fert Cont Rev. 3:1992;3-12.
2. I-Chang C. What we have learned from recent IUD studies a researcher's perspective . Contraception. 48:1993;81-108.
3. Shaarawy M., Naguib Y.A., El-Safory L.S.M., Abdel-Kader M.M. Reactive protein and immunoglobulin levels in women using intrauterine devices. Int J Gynecol Obstet. 19:1981;125-131.
4. Shepard B.L. Endometrial morphological changes in IUD users a review . Contraception. 36:1987;1-10.
5. Tabibzadeh S. Human endometrium an active site of cytokine production and action . Endocr Rev. 12:1991;272-290.
6. Deiter E., Pampfer S., Yeung Y.G., Barad D., Stanly E.R., Pollard J.W. Expression of colony-stimulating factor-1 in the human uterus and placenta. J Clin Endocrinol Metab. 74:1992;850-858.
7. Simon C., Piquette G.N., Frances A., Polan M.L. Localization of IL-1 type receptor and IL-1β in human endometrium throughout the menstrual cycle. J Clin Endocrinol Metab. 77:1993;549-555.
8. Berkowitz R.A., Mostoufizadek M., Kabavat S.E., Golstein D.P., Driscall S.A. Immunologic study of implantation site of molar pregnancy. Am J Obstet Gynecol. 133:1987;925-930.
9. Hill J.A., Haimovici F., Anderson D.J. Products of activated lymphocytes and macrophages inhibit mouse embryo development in vitro. J Immunol. 239:1987;2250-2254.
10. Ämmälä M., Nuyman T., Strengell L., Rutanen E.M. Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium. Fertil Steril. 63:1995;773-778.
11. Piotrow P.T., Reinehart W., Schmidt T.C.S. IUDs up to date, safety, effectiveness and research. Popul Rpt (B). 1979;50. No. 3.
12. Dianarello C.A. Biology of IL-L. FASEB J. 2:1998;108-115.
13. Mills G.B., Hashimoto S., Hurteau J.A., et al. Role of growth factors, their receptors and oncogenes in the diagnosis, prognosis, follow-up and therapy of ovarian cancer. Diag Oncol. 2:1992;39-54.
14. Waldman T.A. The interleukin receptor. J Biol Chem. 266:1991;2681-2684.
15. Rubin L.A., Kurman C.C., Fritz M.E., et al. Soluble IL-2 receptors are released from activated human lymphoid cells in vitro. J Immunol. 135:1985;3172-3177.
16. Rubin L.A., Nelson D. The soluble IL-2 receptor, biology, function, and clinical application. Ann Intern Med. 113:1990;619-645.
17. Nishimoto N. Evaluation of serum IL-6 prior to acute phase proteins on the inflammation by surgical operation. Clin Immunol Immunopathol. 50:1989;399-401.
18. Gnedron R.L., Baines M.G. Infiltrating decidual natural killer cells are associated with spontaneous abortion in mice. Cell Immunol. 113:1988;261-267.
19. Ortiz M.E., Croxatto H.B. The mode of action of IUDs. Contraception. 36:1987;37-53.